ANGPT2 and Hepatic fibrosis: Interestingly, HCV eradication by DAAs was shown to reduce systemic oxidative stress in patients with advanced liver fibrosis [77], while others identified serum angiopoietin-2 (Ang-2) levels as a predictor of regression of liver fibrosis after successful HCV eradication by DAAs [78].